Income Statement GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-09-06 pm EDT			5-day change	1st Jan Change
85.09 ^USD	-2.52%		+0.32%	+10.05%

Sep. 05	Transcript : GE HealthCare Technologies Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 01:05 PM
Sep. 04	Transcript : GE HealthCare Technologies Inc. Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 10:15 AM

d3398326ca69763efd4da3d2c8f5.m-oHE-atCrkCpOQVnT0IZ_w-OhtboXr9CsR9VMprYkQ.zdlRe6T0PJRh4Kh82FhjPppkC0I28y6JOoUlHfIsNhbC3SojrIA-2HLeqQ

Published financial data: GE HEALTHCARE TECHNOLOGIES INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	16.63B	17.16B	17.58B	18.34B	19.55B
Total Revenues	16.63B	17.16B	17.58B	18.34B	19.55B
Cost of Goods Sold, Total	10.08B	10.4B	10.41B	11.16B	11.63B
Gross Profit	6.55B	6.77B	7.17B	7.18B	7.92B
Selling General & Admin Expenses, Total	3.6B	3.24B	3.56B	3.62B	3.77B
R&D Expenses	833M	810M	816M	1.03B	1.2B
Other Operating Expenses, Total	4.43B	4.05B	4.38B	4.65B	4.97B
Operating Income	2.12B	2.72B	2.79B	2.53B	2.95B
Interest Expense, Total	-88M	-66M	-40M	-86M	-542M
Interest And Investment Income	36M	49M	34M	-	26M
Net Interest Expenses	-52M	-17M	-6M	-86M	-516M
Income (Loss) On Equity Invest.	18M	7M	27M	13M	11M
Other Non Operating Income (Expenses)	9M	4M	60M	53M	-84M
EBT, Excl. Unusual Items	2.09B	2.71B	2.88B	2.51B	2.36B
EBT, Incl. Unusual Items	2.09B	2.71B	2.88B	2.51B	2.36B
Income Tax Expense	410M	652M	600M	563M	743M
Earnings From Continuing Operations	1.68B	2.06B	2.28B	1.95B	1.62B
Earnings Of Discontinued Operations	-128M	11.84B	18M	18M	-4M
Net Income to Company	1.55B	13.9B	2.29B	1.97B	1.61B
Minority Interest	-29M	-51M	-46M	-51M	-46M
Net Income - (IS)	1.52B	13.85B	2.25B	1.92B	1.57B
Preferred Dividend and Other Adjustments	-	-	-	-	183M
Net Income to Common Incl Extra Items	1.52B	13.85B	2.25B	1.92B	1.38B
Net Income to Common Excl. Extra Items	1.65B	2.01B	2.23B	1.9B	1.39B
Per Share Items
Net EPS - Basic	-	-	-	-	3.04
Basic EPS - Continuing Operations	-	-	-	-	3.05
Basic Weighted Average Shares Outstanding	-	-	-	-	455M
Net EPS - Diluted	-	-	-	-	3.03
Diluted EPS - Continuing Operations	-	-	-	-	3.04
Diluted Weighted Average Shares Outstanding	-	-	-	-	458M
Normalized Basic EPS	-	-	-	-	3.14
Normalized Diluted EPS	-	-	-	-	3.12
Dividend Per Share	-	-	-	-	0.12
Payout Ratio	-	-	-	-	2.61
Supplemental Items
EBITDA	2.78B	3.35B	3.42B	3.16B	3.56B
EBITA	2.55B	3.12B	3.19B	2.94B	3.31B
EBIT	2.12B	2.72B	2.79B	2.53B	2.95B
EBITDAR	2.99B	3.55B	3.6B	3.38B	3.79B
Total Revenues (As Reported)	16.63B	17.16B	17.58B	18.34B	19.55B
Effective Tax Rate - (Ratio)	19.61	24.06	20.87	22.41	31.47
Current Domestic Taxes	137M	315M	196M	493M	213M
Current Foreign Taxes	293M	463M	422M	324M	345M
Total Current Taxes	430M	778M	618M	817M	558M
Deferred Domestic Taxes	-110M	3M	83M	-261M	82M
Deferred Foreign Taxes	90M	-129M	-101M	7M	103M
Total Deferred Taxes	-20M	-126M	-18M	-254M	185M
Normalized Net Income	1.28B	1.64B	1.75B	1.52B	1.43B
Interest on Long-Term Debt	-	-	-	-	616M
Non-Cash Pension Expense	8M	4M	1M	-10M	-301M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	833M	810M	816M	1.03B	1.2B
Net Rental Expense, Total	211M	201M	185M	217M	229M
Imputed Operating Lease Interest Expense	-	-	1.64B	32.91M	107M
Imputed Operating Lease Depreciation	-	-	-1.46B	184M	122M
Stock-Based Comp., Other (Total)	-	-	-	-	114M
Total Stock-Based Compensation	-	-	-	-	114M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	-	1.01B	556M	1.44B	2.49B
Total Cash And Short Term Investments	-	1.01B	556M	1.44B	2.49B
Accounts Receivable, Total	-	2.36B	3.66B	3.6B	3.84B
Other Receivables	-	-	-	291M	316M
Notes Receivable	-	125M	99M	97M	97M
Total Receivables	-	2.48B	3.76B	3.99B	4.25B
Inventory	-	1.59B	1.95B	2.16B	1.96B
Prepaid Expenses	-	144M	163M	163M	147M
Restricted Cash	-	-	-	5M	10M
Other Current Assets, Total	-	671M	576M	562M	545M
Total Current Assets	-	5.9B	7B	8.32B	9.41B
Gross Property Plant And Equipment	-	4.89B	5.05B	5.3B	5.56B
Accumulated Depreciation	-	-2.69B	-2.82B	-2.99B	-3.06B
Net Property Plant And Equipment	-	2.2B	2.24B	2.31B	2.5B
Long-term Investments	-	344M	341M	322M	357M
Goodwill	-	11.87B	12.89B	12.81B	12.94B
Other Intangibles, Total	-	1.6B	1.85B	1.52B	1.25B
Accounts Receivable Long-Term	-	15M	19M	86M	97M
Loans Receivable Long-Term	-	230M	186M	196M	178M
Deferred Tax Assets Long-Term	-	1.49B	1.29B	1.55B	4.47B
Deferred Charges Long-Term	-	71M	77M	82M	96M
Other Long-Term Assets, Total	-	510M	424M	338M	1.15B
Total Assets	-	24.23B	26.31B	27.54B	32.45B
Liabilities
Accounts Payable, Total	-	2.16B	2.54B	2.94B	2.95B
Accrued Expenses, Total	-	-	-	1.33B	1.99B
Current Portion of Long-Term Debt	-	4M	6M	15M	1.01B
Current Portion of Leases	-	-	-	104M	110M
Unearned Revenue Current, Total	-	1.81B	1.86B	1.9B	1.92B
Other Current Liabilities	-	2.54B	2.35B	899M	1.01B
Total Current Liabilities	-	6.52B	6.76B	7.19B	8.98B
Long-Term Debt	-	31M	31M	8.23B	8.44B
Long-Term Leases	-	-	-	282M	311M
Unearned Revenue Non Current	-	-	-	630M	705M
Pension & Other Post Retirement Benefits	-	805M	751M	549M	5.78B
Deferred Tax Liability Non Current	-	459M	385M	370M	68M
Other Non Current Liabilities	-	1.44B	1.48B	691M	861M
Total Liabilities	-	9.25B	9.41B	17.95B	25.14B
Common Stock, Total	-	15.57B	17.69B	11.24B	5M
Additional Paid In Capital	-	-	-	-	6.49B
Retained Earnings	-	-	-	-	1.33B
Comprehensive Income and Other	-	-839M	-1.04B	-1.88B	-691M
Total Common Equity	-	14.73B	16.66B	9.36B	7.13B
Minority Interest	-	247M	241M	235M	177M
Total Equity	-	14.97B	16.9B	9.59B	7.31B
Total Liabilities And Equity	-	24.23B	26.31B	27.54B	32.45B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	-	-	454M	455M
ECS Total Common Shares Outstanding	-	-	-	-	455M
Book Value / Share	-	-	-	-	15.67
Tangible Book Value	-	1.26B	1.92B	-4.98B	-7.06B
Tangible Book Value Per Share	-	-	-	-	-15.5
Total Debt	-	35M	37M	8.64B	9.86B
Net Debt	-	-972M	-519M	7.2B	7.37B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	511M	387M	278M	3.53B
Debt Equivalent Oper. Leases	1.69B	1.61B	1.48B	1.74B	1.83B
Minority Interest, Total (Incl. Fin. Div)	-	247M	241M	235M	177M
Equity Method Investments, Total	-	344M	341M	322M	357M
Account Code - Inventory Valuation	-	-	5	5	5
Inventories - Raw Materials, Total	-	726M	900M	1.05B	961M
Inventories - Work In Process, Total	-	62M	104M	91M	91M
Inventories - Finished Goods, Total	-	806M	942M	1.01B	908M
Land - (BS)	-	70M	77M	70M	70M
Buildings, Total	-	1.74B	1.76B	1.89B	1.96B
Machinery, Total	-	2.35B	2.47B	2.54B	2.62B
Full Time Employees	-	-	51K	50K	51K
Accumulated Allowance for Doubtful Accounts (Supple)	-	93M	107M	91M	98M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	1.52B	13.85B	2.25B	1.92B	1.57B
Depreciation & Amortization - CF	225M	222M	225M	228M	248M
Amortization of Goodwill and Intangible Assets - (CF)	434M	408M	400M	405M	362M
Depreciation & Amortization, Total	659M	630M	625M	633M	610M
Stock-Based Compensation (CF)	-	-	-	-	114M
Net Cash From Discontinued Operations	151M	-931M	-	-21M	-
Other Operating Activities, Total	64M	-11.94B	13M	-320M	-387M
Change In Accounts Receivable	-254M	-278M	-1.31B	-453M	-175M
Change In Inventories	-173M	100M	-435M	-402M	111M
Change In Accounts Payable	-1M	-113M	263M	481M	-13M
Change in Unearned Revenues	-47M	312M	-21M	138M	26M
Change in Other Net Operating Assets	66M	66M	228M	141M	247M
Cash from Operations	1.99B	1.69B	1.61B	2.11B	2.1B
Capital Expenditure	-263M	-237M	-242M	-310M	-387M
Sale of Property, Plant, and Equipment	52M	16M	15M	4M	1M
Cash Acquisitions	-	-78M	-1.48B	-	-147M
Sale (Purchase) of Intangible assets	-68M	-22M	-6M	-	-
Other Investing Activities, Total	-46M	20.31B	-47M	-92M	-25M
Cash from Investing	-325M	19.99B	-1.76B	-398M	-558M
Short Term Debt Issued, Total	-	-	-	9M	-
Long-Term Debt Issued, Total	4M	4M	5M	8.2B	2.01B
Total Debt Issued	4M	4M	5M	8.21B	2.01B
Short Term Debt Repaid, Total	-	-10M	-7M	-	-12M
Long-Term Debt Repaid, Total	-63M	-10M	-10M	-3M	-855M
Total Debt Repaid	-63M	-20M	-17M	-3M	-867M
Common Dividends Paid	-	-	-	-	-41M
Common & Preferred Stock Dividends Paid	-	-	-	-	-41M
Other Financing Activities, Total	-1.52B	-21.53B	-251M	-9.03B	-1.58B
Cash from Financing	-1.57B	-21.54B	-263M	-822M	-478M
Foreign Exchange Rate Adjustments	-55M	14M	-34M	-3M	-10M
Net Change in Cash	35M	143M	-451M	890M	1.06B
Supplemental Items
Cash Interest Paid	73M	46M	21M	-	570M
Cash Income Tax Paid (Refund)	-	-	-	-	474M
Levered Free Cash Flow	-	-	778M	1.84B	2.6B
Unlevered Free Cash Flow	-	-	803M	1.89B	2.94B
Change In Net Working Capital	-	-	1.32B	11M	-755M
Net Debt Issued / Repaid	-59M	-16M	-12M	8.2B	1.14B

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-	-	6.91	5.88	6.15
Return on Total Capital	-	-	10.93	8.9	10.42
Return On Equity %	-	-	14.28	14.72	19.15
Return on Common Equity	-	-	14.21	14.59	16.85
Margin Analysis
Gross Profit Margin %	39.37	39.43	40.8	39.14	40.52
SG&A Margin	21.64	18.88	20.27	19.74	19.27
EBITDA Margin %	16.68	19.49	19.44	17.26	18.21
EBITA Margin %	15.33	18.2	18.16	16.01	16.94
EBIT Margin %	12.72	15.82	15.89	13.81	15.09
Income From Continuing Operations Margin %	10.11	11.99	12.94	10.63	8.28
Net Income Margin %	9.16	80.67	12.78	10.45	8.02
Net Avail. For Common Margin %	9.93	11.69	12.68	10.35	7.1
Normalized Net Income Margin	7.68	9.57	9.96	8.28	7.31
Levered Free Cash Flow Margin	-	-	4.43	10.04	13.28
Unlevered Free Cash Flow Margin	-	-	4.57	10.33	15.02
Asset Turnover
Asset Turnover	-	-	0.7	0.68	0.65
Fixed Assets Turnover	-	-	7.93	8.06	8.12
Receivables Turnover (Average Receivables)	-	-	5.85	5.27	5.25
Inventory Turnover (Average Inventory)	-	-	5.88	5.44	5.65
Short Term Liquidity
Current Ratio	-	0.9	1.04	1.16	1.05
Quick Ratio	-	0.52	0.62	0.74	0.74
Operating Cash Flow to Current Liabilities	-	0.26	0.24	0.29	0.23
Days Sales Outstanding (Average Receivables)	-	-	62.42	69.24	69.5
Days Outstanding Inventory (Average Inventory)	-	-	62.05	67.05	64.57
Average Days Payable Outstanding	-	-	79.73	88.02	94.02
Cash Conversion Cycle (Average Days)	-	-	44.75	48.28	40.06
Long Term Solvency
Total Debt/Equity	-	0.23	0.22	90.02	134.92
Total Debt / Total Capital	-	0.23	0.22	47.37	57.43
LT Debt/Equity	-	0.21	0.18	88.78	119.66
Long-Term Debt / Total Capital	-	0.21	0.18	46.72	50.93
Total Liabilities / Total Assets	-	38.2	35.78	65.17	77.48
EBIT / Interest Expense	24.05	41.15	69.85	29.44	5.44
EBITDA / Interest Expense	31.53	50.7	85.48	39.33	6.99
(EBITDA - Capex) / Interest Expense	28.55	47.11	79.42	35.72	6.28
Total Debt / EBITDA	-	0.01	0.01	2.55	2.6
Net Debt / EBITDA	-	-0.29	-0.15	2.13	1.94
Total Debt / (EBITDA - Capex)	-	0.01	0.01	2.81	2.9
Net Debt / (EBITDA - Capex)	-	-0.31	-0.16	2.34	2.17
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	3.19	2.45	4.3	6.6
Gross Profit, 1 Yr. Growth %	-	3.34	6.01	0.07	10.35
EBITDA, 1 Yr. Growth %	-	20.58	2.18	-7.43	12.48
EBITA, 1 Yr. Growth %	-	22.51	2.24	-8.05	12.77
EBIT, 1 Yr. Growth %	-	28.36	2.87	-9.38	16.51
Earnings From Cont. Operations, 1 Yr. Growth %	-	22.43	10.54	-14.33	-16.98
Net Income, 1 Yr. Growth %	-	808.53	-83.77	-14.73	-18.16
Normalized Net Income, 1 Yr. Growth %	-	28.55	6.58	-13.24	-5.88
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-	-	-27.27
Accounts Receivable, 1 Yr. Growth %	-	-	55.41	7.48	6.55
Inventory, 1 Yr. Growth %	-	-	22.08	10.74	-9.05
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	1.5	3.53	8.04
Total Assets, 1 Yr. Growth %	-	-	8.59	4.68	17.85
Tangible Book Value, 1 Yr. Growth %	-	-	52.55	-359.71	41.8
Common Equity, 1 Yr. Growth %	-	-	13.09	-43.82	-23.77
Cash From Operations, 1 Yr. Growth %	-	-15.18	-4.74	31.49	-0.57
Capital Expenditures, 1 Yr. Growth %	-	-9.89	2.11	28.1	24.84
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-	173.82	36.13
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-	171.71	49.67
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	2.82	3.37	5.44
Gross Profit, 2 Yr. CAGR %	-	-